Biobank For MS And Other Demyelinating Diseases - Full Text View

Sponsored by:	Accelerated Cure Project for Multiple Sclerosis
Information provided by:	Accelerated Cure Project for Multiple Sclerosis
ClinicalTrials.gov Identifier:	NCT00445367

Purpose

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Condition
Multiple Sclerosis Transverse Myelitis Neuromyelitis Optica Acute Disseminated Encephalomyelitis Optic Neuritis

MedlinePlus related topics: Multiple Sclerosis

U.S. FDA Resources

Study Type:	Observational
Official Title:	Large-Scale, Multi-Disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases

Further study details as provided by Accelerated Cure Project for Multiple Sclerosis:

Study Start Date:

May 2006

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture
experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

Exclusion Criteria:

history of blood borne pathogens
allogeneic bone marrow transplant
clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
weight less than 37 pounds

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00445367

Contacts

Contact: Sara Loud	781-487-0008	acp-study-director0807@acceleratedcure.org
Contact: Email: acp-study-director0807 /at/ acceleratedcure.org

Locations

United States, Arizona
Barrow Neurological Institute	Recruiting
Phoenix, Arizona, United States, 85013
Contact: Breanna Bullock 602-406-6211
Contact: Email: acp-study-barrow0807 /at/ acceleratedcure.org
Principal Investigator: Timothy Vollmer, M.D.
United States, Georgia
Shepherd Center	Recruiting
Atlanta, Georgia, United States, 30309
Contact: Elizabeth Iski 404-350-3116
Contact: Email: acp-study-shepherd0807 /at/ acceleratedcure.org
Principal Investigator: Benjamin Thrower, M.D.
United States, Maryland
Johns Hopkins	Recruiting
Baltimore, Maryland, United States, 21287
Contact: Jana Goins 410-502-6160
Contact: Email: acp-study-hopkins0807 /at/ acceleratedcure.org
Principal Investigator: Ben Greenberg, M.D., M.H.S.
United States, Massachusetts
University of Massachusetts Medical School	Recruiting
Worcester, Massachusetts, United States, 01605
Contact: Janice Weaver 508-793-6562
Contact: Email: acp-study-umass0807 /at/ acceleratedcure.org
Principal Investigator: Peter Riskind, M.D.
United States, New York
Multiple Sclerosis Research Center of New York	Recruiting
New York, New York, United States, 10019
Contact: Lauren Puccio 212-265-8070
Contact: Email: acp-study-msrcny0807 /at/ acceleratedcure.org
Principal Investigator: Saud Sadiq, M.D.
United States, Texas
University of Texas Southwestern Medical Center at Dallas	Recruiting
Dallas, Texas, United States, 76051
Contact: Deborah Albritton 214-645-8800
Contact: Email: acp-study-utsw0807 /at/ acceleratedcure.org
Principal Investigator: Elliot Frohman, M.D.

Sponsors and Collaborators

Accelerated Cure Project for Multiple Sclerosis

Investigators

Principal Investigator:

Benjamin Greenberg, M.D., M.H.S.

Johns Hopkins

More Information

Accelerated Cure Project MS Repository Overview This link exits the ClinicalTrials.gov site

Study ID Numbers:	ACP-001
Study First Received:	March 8, 2007
Last Updated:	May 8, 2008
ClinicalTrials.gov Identifier:	NCT00445367
Health Authority:	United States: Institutional Review Board

Keywords provided by Accelerated Cure Project for Multiple Sclerosis:

Multiple Sclerosis
Clinically Isolated Syndrome
Transverse Myelitis
Neuromyelitis Optica

Acute Disseminated Encephalomyelitis
Optic Neuritis
Repository
Biobank

Study placed in the following topic categories:

Acute disseminated encephalomyelitis
Papillitis
Spinal Cord Diseases
Neuromyelitis Optica
Demyelinating diseases
Encephalomyelitis, Acute Disseminated
Encephalomyelitis
Brain Diseases
Neurodegenerative Diseases
Neuritis
Multiple Sclerosis
Neuromuscular Diseases
Myelitis, Transverse
Autoimmune Diseases of the Nervous System
Nervous System Neoplasms

Optic Neuritis
Devic disease
Autoimmune Diseases
Demyelinating Diseases
Eye Diseases
Central Nervous System Diseases
Sclerosis
Optic nerve disorder
Encephalitis
Virus Diseases
Paraneoplastic Syndromes
Central Nervous System Infections
Peripheral Nervous System Diseases
Demyelinating Autoimmune Diseases, CNS
Optic Nerve Diseases

Additional relevant MeSH terms:

Neoplasms
Pathologic Processes
Neoplasms by Site
Immune System Diseases

Nervous System Diseases
Central Nervous System Viral Diseases
Cranial Nerve Diseases

ClinicalTrials.gov processed this record on January 16, 2009